The Prague Post - Japan biochemist who discovered statins, Akira Endo, dies

EUR -
AED 4.301814
AFN 77.708293
ALL 96.176014
AMD 446.924892
ANG 2.097203
AOA 1074.135394
ARS 1698.74032
AUD 1.770078
AWG 2.108444
AZN 1.991912
BAM 1.950236
BBD 2.36247
BDT 143.341038
BGN 1.955079
BHD 0.441654
BIF 3477.877376
BMD 1.171358
BND 1.512285
BOB 8.104876
BRL 6.444114
BSD 1.172958
BTN 106.59388
BWP 15.491801
BYN 3.437408
BYR 22958.617481
BZD 2.359079
CAD 1.615232
CDF 2635.555553
CHF 0.933339
CLF 0.027334
CLP 1072.249192
CNY 8.248644
CNH 8.245095
COP 4499.162784
CRC 585.330013
CUC 1.171358
CUP 31.040988
CVE 109.951301
CZK 24.352124
DJF 208.874957
DKK 7.471771
DOP 75.364979
DZD 151.627638
EGP 55.766478
ERN 17.570371
ETB 182.088389
FJD 2.670112
FKP 0.872551
GBP 0.87877
GEL 3.15685
GGP 0.872551
GHS 13.489513
GIP 0.872551
GMD 86.100851
GNF 10199.898985
GTQ 8.982373
GYD 245.399857
HKD 9.112316
HNL 30.903829
HRK 7.536638
HTG 153.611735
HUF 387.432543
IDR 19557.696563
ILS 3.773032
IMP 0.872551
INR 105.882157
IQD 1536.622469
IRR 49340.51376
ISK 148.001104
JEP 0.872551
JMD 188.262873
JOD 0.830488
JPY 182.223503
KES 151.004694
KGS 102.43541
KHR 4696.600275
KMF 491.969805
KPW 1054.235599
KRW 1732.367947
KWD 0.359502
KYD 0.977515
KZT 604.617565
LAK 25412.604561
LBP 105039.563247
LKR 363.105585
LRD 207.617653
LSL 19.697785
LTL 3.458716
LVL 0.708543
LYD 6.354896
MAD 10.733975
MDL 19.752728
MGA 5298.881924
MKD 61.532571
MMK 2460.108883
MNT 4156.475757
MOP 9.398924
MRU 46.520274
MUR 53.941062
MVR 18.050801
MWK 2033.897151
MXN 21.056371
MYR 4.7891
MZN 74.861814
NAD 19.697785
NGN 1705.356781
NIO 43.166842
NOK 11.969757
NPR 170.550408
NZD 2.028622
OMR 0.450384
PAB 1.172953
PEN 3.951227
PGK 4.986772
PHP 68.718886
PKR 328.725128
PLN 4.214535
PYG 7878.555568
QAR 4.276698
RON 5.092357
RSD 117.397841
RUB 94.202038
RWF 1707.82745
SAR 4.39328
SBD 9.562266
SCR 15.804605
SDG 704.56838
SEK 10.937063
SGD 1.513547
SHP 0.878822
SLE 27.872113
SLL 24562.796602
SOS 670.387339
SRD 45.305812
STD 24244.746356
STN 24.430299
SVC 10.263761
SYP 12951.888916
SZL 19.680933
THB 36.933012
TJS 10.779545
TMT 4.111467
TND 3.425327
TOP 2.820349
TRY 50.041619
TTD 7.957331
TWD 36.794115
TZS 2900.810779
UAH 49.466868
UGX 4176.08534
USD 1.171358
UYU 45.889075
UZS 14222.422448
VES 320.06667
VND 30847.713845
VUV 142.118205
WST 3.269295
XAF 654.090834
XAG 0.017758
XAU 0.000271
XCD 3.165653
XCG 2.113978
XDR 0.813479
XOF 654.093618
XPF 119.331742
YER 279.193074
ZAR 19.608123
ZMK 10543.631377
ZMW 26.949227
ZWL 377.176809
  • SCS

    0.0200

    16.14

    +0.12%

  • RBGPF

    0.4100

    82.01

    +0.5%

  • CMSC

    0.0400

    23.34

    +0.17%

  • RYCEF

    -0.3100

    14.64

    -2.12%

  • RIO

    0.1700

    75.99

    +0.22%

  • BCC

    0.5100

    75.84

    +0.67%

  • BTI

    -0.4500

    57.29

    -0.79%

  • NGG

    -0.2600

    75.77

    -0.34%

  • BCE

    -0.2800

    23.33

    -1.2%

  • GSK

    -0.4600

    48.78

    -0.94%

  • VOD

    0.0000

    12.7

    0%

  • JRI

    -0.0500

    13.51

    -0.37%

  • RELX

    -0.2600

    40.82

    -0.64%

  • CMSD

    0.0150

    23.38

    +0.06%

  • BP

    -1.4900

    33.76

    -4.41%

  • AZN

    -0.2100

    91.35

    -0.23%

Japan biochemist who discovered statins, Akira Endo, dies
Japan biochemist who discovered statins, Akira Endo, dies / Photo: Paul J. RICHARDS - AFP

Japan biochemist who discovered statins, Akira Endo, dies

Japanese biochemist Akira Endo, who discovered cholesterol-lowering statins, has died aged 90, his former student and colleague said on Tuesday.

Text size:

Statins, which can prevent heart attacks or strokes, are among the most commonly prescribed drugs worldwide.

Keiji Hasumi, a professor who was a long-time associate of Endo, said the scientist had died on June 5.

"His work was truly great. Statins didn't exist before Endo," Hasumi told AFP. "It has the same value and impact as the discovery of penicillin."

Johns Hopkins Medicine says more than 200 million people take statins. Studies say the global market for them was worth $15 billion in 2023 and is expected to grow.

Endo experimented on thousands of microbes to reach his 1973 discovery of mevastatin -- an agent derived from penicillin that reduces so-called "bad" cholesterol in the blood.

The researcher "was a tough, strict person. He was insightful and perceptive," and "able to see the hidden essence of things", Hasumi said.

Endo was born in 1933 to a farming family in rural northern Japan.

His ambitions began early thanks to his grandfather, who was interested in medicine and became a "great home teacher", Endo said in a 2008 autobiographical essay.

As a student, Endo became interested in antibiotics like penicillin, "deeply impressed" by how many lives they had saved, his essay in the journal Nature Medicine said.

Endo carried out research in New York in the late 1960s, when coronary heart disease was the main cause of US deaths.

"I often saw ambulances coming to take elderly people who had suffered a heart attack to hospital", which "made me realise the importance of developing a cholesterol-lowering drug", he said.

Endo worked at the Tokyo University of Agriculture and Technology, which issued a statement expressing condolences over his death, and at Japanese drugmaker Sankyo, now a part of Daiichi-Sankyo.

He spent two years testing 6,000 strains of microbe in the search for a new drug that could help achieve his goal before finally finding mevastatin.

Conflicting reports on the benefits and potential harms of statins in recent years have prompted some people prescribed the drugs to stop taking them.

"Are statins safe? For most people, the answer is a resounding yes, according to a 2014 Johns Hopkins meta-analysis of 20 years worth of published research," the US university says.

Endo was a strong candidate for a Nobel Prize, but never won. In a report on his death, Japanese broadcaster NHK noted Endo had received other accolades, including being honoured as a Person of Cultural Merit by the government in 2011.

His discovery "was the result of many twists and turns", Hasumi said.

"He reached his goal by overcoming so many challenges, without which medicines cannot be created, I think I remember him saying."

H.Dolezal--TPP